Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03655613
What this trial is testing

APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC

Who this might be right for
Hepatocellular CarcinomaRenal Cell Carcinoma
Apollomics (Australia) Pty. Ltd. 20
Early research (Phase 1)Study completedNCT02298946
What this trial is testing

AMP-224, a PD-1 Inhibitor, With Stereotactic Body Radiation Therapy in Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Carcinoma
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Ended earlyNCT03637803
What this trial is testing

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Who this might be right for
OncologySolid TumorNon Small Cell Lung Cancer+3 more
4D pharma plc 63
Testing effectiveness (Phase 2)Looking for participantsNCT07071103
What this trial is testing

Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Malignant Solid Tumors

Who this might be right for
RadiotherapyMetastatic Solid CancersImmune Checkpoint Blockade+3 more
Chuangzhen Chen 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT04652076
What this trial is testing

GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab

Who this might be right for
Endometrial CarcinomaCervix Carcinoma
NETRIS Pharma 240
Not applicableLooking for participantsNCT07185243
What this trial is testing

Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
Hangzhou Converd Co., Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT07312422
What this trial is testing

LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study

Who this might be right for
Pancreatic CancerPD-L1PD-1 Inhibitor+2 more
Zhejiang Provincial People's Hospital 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT05507541
What this trial is testing

TTI-622 in Combination With Pembrolizumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Recurrent ALK Positive Large B-Cell LymphomaRecurrent B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation+25 more
Mayo Clinic 10
Testing effectiveness (Phase 2)UnknownNCT05520853
What this trial is testing

SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC

Who this might be right for
Stereotactic Body Radiation Therapy; PD-1 Inhibitor; Hyperthermia; NSCLC
First People's Hospital of Hangzhou 63
Not applicableLooking for participantsNCT07100405
What this trial is testing

TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment

Who this might be right for
Hepatocellular Carcinoma
Fudan University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06547203
What this trial is testing

Cetuximab, Irinotecan, Toripalimab in RAS/BRAF Wild-type Ultraselected Right-sided Colorectal Cancer Study

Who this might be right for
Colorectal Cancer Metastatic
Sun Yat-sen University 34
Testing effectiveness (Phase 2)Looking for participantsNCT06482801
What this trial is testing

Checkpoint Inhibitor Combinations Therapy as First Line for HCC Via IT

Who this might be right for
Liver CancerAntibody
Second Affiliated Hospital of Guangzhou Medical University 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07230314
What this trial is testing

Sequential Transarterial Chemoembolization (TACE), Stereotactic Body Radiation Therapy (SBRT), and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma Treated With Donafenib

Who this might be right for
Unresectable Hepatocellular Carcinoma
Jinling Hospital, China 34
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07780877
What this trial is testing

Response-adapted Postoperative Radiotherapy In Locally Advanced Head and Neck Cancer

Who this might be right for
Head & Neck Squamous Cell CarcinomaLocally Advanced Head and Neck Squamous Cell Carcinoma
Fudan University 85
Testing effectiveness (Phase 2)WithdrawnNCT02639234
What this trial is testing

Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung CancerMetastatic Non-small Cell Lung CancerLung Neoplasms
Gradalis, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT07198165
What this trial is testing

SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC

Who this might be right for
Rectal CancerRectal AdenocarcinomaRectal Cancer, Radiotherapy+6 more
Ruijin Hospital 104
Very early researchStudy completedNCT03158883
What this trial is testing

UCDCC#270: Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients

Who this might be right for
Metastatic Non-small Cell Lung Cancer (NSCLC)
Megan Daly, MD 8
Testing effectiveness (Phase 2)UnknownNCT04624984
What this trial is testing

PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL

Who this might be right for
Classical Hodgkin LymphomaRefractory or Relapsed Classical Hodgkin Lymphoma
Sun Yat-sen University 42
Early research (Phase 1)UnknownNCT05273814
What this trial is testing

Study of Chemotherapy and PD-1 Inhibitor Combination With Anti-angiogenesis to Treat Elderly Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06696742
What this trial is testing

PD1 Inhibitors Combined With Clostridium Butyricum for Urothelial Carcinoma

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
The First Affiliated Hospital with Nanjing Medical University 60
Next Page